Sign in

CIK 0000926617

  • Non-accelerated filer
  • Smaller reporting company

Aspira Women's Health Inc.

Sign in to watch
Ticker
AWHL
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330595156
Phone
+1 512-519-0400
Business address
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
Former names
VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 80 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2011-09-01 Creech William B. VP Sales and Marketing Purchase +717 $2.81 $2K 24,680
2011-08-12 Creech William B. VP Sales and Marketing Purchase +1,000 $2.75 $3K 23,963
2011-08-01 Creech William B. VP Sales and Marketing Purchase +500 $4.16 $2K 22,963
2011-07-01 Creech William B. VP Sales and Marketing Purchase +489 $4.04 $2K 22,463
2011-06-09 Fung Eric T S.V.P & C.S.O Purchase +1,000 $4.72 $5K 52,471
2011-06-08 Severinghaus Carl Director Sale −4,000 $4.98 $20K 27,500
2011-06-01 Creech William B. VP Sales and Marketing Purchase +374 $5.28 $2K 21,974
2011-03-22 RODDY PETER S Director Grant or award +18,200 33,700
2011-03-22 WALLEN WILLIAM C Director Grant or award +19,200 41,200
2011-03-22 Burns James S Director Grant or award +15,200 88,708
2011-03-22 HAMILTON JOHN F Director Grant or award +15,200 88,708
2011-03-22 Severinghaus Carl Director Grant or award +20,000 31,500
2011-03-22 Fung Eric T SVP and Chief Science Officer Grant or award +41,000 51,471
2011-03-18 GARDINER SANDRA VP & Chief Financial Officer Grant or award +24,000 24,000
2011-03-18 PAGE GAIL S Chief Executive Officer Grant or award +85,000 224,907
2011-03-18 Creech William B. VP Sales and Marketing Grant or award +20,000 21,600
2011-03-18 Kohli Ashish VP of Corporate Strategy Grant or award +7,000 11,500
2010-12-15 Severinghaus Carl Director Sale −3,500 $5.45 $19K 11,500
2010-12-14 PAGE GAIL S Chief Executive Officer Sale −45,000 $5.92 $266K 139,907
2010-12-14 Severinghaus Carl Director Sale −2,500 $6.00 $15K 15,000

Page 29 of 32 · 629 trades